Literature DB >> 19564469

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.

Søren S Lund, Allan A Vaag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19564469     DOI： 10.2337/dc09-9030

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  4 in total

1.  Design of the Lifestyle Improvement through Food and Exercise (LIFE) study: a randomized controlled trial of self-management of type 2 diabetes among African American patients from safety net health centers.

Authors:  Elizabeth B Lynch; Rebecca Liebman; Jennifer Ventrelle; Kathryn Keim; Bradley M Appelhans; Elizabeth F Avery; Bettina Tahsin; Hong Li; Merle Shapera; Leon Fogelfeld
Journal:  Contemp Clin Trials       Date:  2014-09-22       Impact factor: 2.226

Review 2.  Intensive glycemic control and cardiovascular disease: an update.

Authors:  Aparna Brown; L Raymond Reynolds; Dennis Bruemmer
Journal:  Nat Rev Cardiol       Date:  2010-04-20       Impact factor: 32.419

3.  Mexican American trial of community health workers: a randomized controlled trial of a community health worker intervention for Mexican Americans with type 2 diabetes mellitus.

Authors:  Steven K Rothschild; Molly A Martin; Susan M Swider; Carmen M Tumialán Lynas; Imke Janssen; Elizabeth F Avery; Lynda H Powell
Journal:  Am J Public Health       Date:  2013-08-15       Impact factor: 9.308

4.  Roles of Cardiometabolic Factors in Mediating the Causal Effect of Type 2 Diabetes on Cardiovascular Diseases: A Two-Step, Two-Sample Multivariable Mendelian Randomization Study.

Authors:  Ken Chen; Zhenhuang Zhuang; Chunli Shao; Jilin Zheng; Qing Zhou; Erdan Dong; Tao Huang; Yi-Da Tang
Journal:  Front Cardiovasc Med       Date:  2022-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.